The sTREM2 Concentrations in the Blood: A Marker of Neurodegeneration?

The sTREM2 Concentrations in the Blood: A Marker of Neurodegeneration?

Microglia performs a variety of functions during brain development designed to maintain brain homeostasis. Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed in microglial cells modulating phagocytosis, cytokine production, cell proliferation, and cell survival. Interestingly, the...

Full description

Bibliographic Details
Main Authors:	Evelyn Ferri, Paolo Dionigi Rossi, Annalisa Geraci, Simona Ciccone, Matteo Cesari, Beatrice Arosio
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Molecular Biosciences
Subjects:	TREM2 Alzheimer's disease idiopathic normal pressure hydrocephalus neurodegeneration biomarker
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2020.627931/full

Similar Items

Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
by: Ling-Zhi Ma, et al.
Published: (2020-04-01)

Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration
by: Nicolai Franzmeier, et al.
Published: (2020-10-01)

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
by: Marc Suárez‐Calvet, et al.
Published: (2018-12-01)

Novel Insight in Idiopathic Normal Pressure Hydrocephalus (iNPH) Biomarker Discovery in CSF
by: Enrica Torretta, et al.
Published: (2021-07-01)

Leishmania infantum Induces the Release of sTREM-1 in Visceral Leishmaniasis
by: Lays G. S. Bomfim, et al.
Published: (2017-11-01)

New insights into the role of TREM2 in Alzheimer’s disease
by: Maud Gratuze, et al.
Published: (2018-12-01)

Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
by: Marc Suárez-Calvet, et al.
Published: (2019-01-01)

CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
by: Kristi Henjum, et al.
Published: (2018-11-01)

Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes
by: Jagan A. Pillai, et al.
Published: (2021-06-01)

Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS
by: Anna Kiialainen, et al.
Published: (2005-03-01)

The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
by: Xianyuan Xiang, et al.
Published: (2018-09-01)

Detection of sTREM⁃1 levels in gingival crevicular fluid of peri⁃implantitis
by: ZHENG Dechun, et al.
Published: (2017-12-01)

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
by: Michael Ewers, et al.
Published: (2020-09-01)

TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
by: Jorge L. Del-Aguila, et al.
Published: (2019-05-01)

TREM2 Mediates Microglial Anti-Inflammatory Activations in Alzheimer’s Disease: Lessons Learned from Transcriptomics
by: Feng Xue, et al.
Published: (2021-02-01)

Predictive Value of Serial Measurements of sTREM-1 in the Treatment Response of Patients with Community-acquired Pneumonia
by: Wen-Cheng Chao, et al.
Published: (2007-01-01)

Function of TREM1 and TREM2 in Liver-Related Diseases
by: Huifang Sun, et al.
Published: (2020-12-01)

Long term prognosis of ventriculoatrial shunt for idiopathic normal pressure hydrocephalus in the elderly
by: Tsukasa Kawase, et al.
Published: (2017-12-01)

TREM Receptors Connecting Bowel Inflammation to Neurodegenerative Disorders
by: Gianfranco Natale, et al.
Published: (2019-09-01)

Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
by: Brittani R. Price, et al.
Published: (2020-08-01)

TREM2-Dependent Effects on Microglia in Alzheimer’s Disease
by: Yingyue Zhou, et al.
Published: (2018-07-01)

TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
by: Honghua Zheng, et al.
Published: (2018-11-01)

Characterizing biomarker features of cognitively normal individuals with ventriculomegaly
by: Xiaofeng Li, et al.
Published: (2018-01-01)

sTREM-1 predicts mortality in hospitalized patients with infection in a tropical, middle-income country
by: Shelton W. Wright, et al.
Published: (2020-07-01)

Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
by: Nicholas J. Ashton, et al.
Published: (2019-11-01)

The Emerging Roles and Therapeutic Potential of Soluble TREM2 in Alzheimer’s Disease
by: Li Zhong, et al.
Published: (2019-11-01)

Idiopathic normal pressure hydrocephalus
by: D. Adam, et al.
Published: (2019-09-01)

TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
by: Shane M. Bemiller, et al.
Published: (2017-10-01)

Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism
by: Julia K Götzl, et al.
Published: (2019-06-01)

Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
by: Nicholas F. Fitz, et al.
Published: (2020-07-01)

Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)
by: Li Zhong, et al.
Published: (2018-03-01)

High‐affinity interactions and signal transduction between Aβ oligomers and TREM2
by: Christian B Lessard, et al.
Published: (2018-11-01)

Soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) and polymorphic variants of TREM-1 in the development of multiple organ dysfunction syndrome after coronary artery bypass grafting
by: M. V. Khutornya, et al.
Published: (2019-07-01)

Frontotemporal dementia as a comorbidity to idiopathic normal pressure hydrocephalus (iNPH): a short review of literature and an unusual case
by: V. E. Korhonen, et al.
Published: (2017-04-01)

Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus
by: B. G. Adleyba, et al.
Published: (2019-03-01)

Plasmonic Interferometers as TREM2 Sensors for Alzheimer’s Disease
by: Dingdong Li, et al.
Published: (2021-07-01)

Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities
by: Hailan Yao, et al.
Published: (2019-10-01)

Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis
by: Zhongyun Chen, et al.
Published: (2017-05-01)

Comparative analysis of cerebrospinal fluid metabolites in Alzheimer’s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort
by: Yuki Nagata, et al.
Published: (2018-01-01)

Sarcopenia and Menopause: The Role of Estradiol
by: Annalisa Geraci, et al.
Published: (2021-05-01)